This is a Validated Antibody Database (VAD) review about mouse Cldn5, based on 157 published articles (read how Labome selects the articles), using Cldn5 antibody in all methods. It is aimed to help Labome visitors find the most suited Cldn5 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Cldn5 synonym: AI854493; MBEC1; Tmvcf

Knockout validation
Invitrogen
mouse monoclonal (4C3C2)
  • immunohistochemistry knockout validation; zebrafish ; 1:150; loading ...; fig 1b
  • immunohistochemistry - frozen section; human; 1:150; loading ...; fig s1a
  • immunohistochemistry - frozen section; mouse; 1:150; loading ...; fig s1b
Invitrogen Cldn5 antibody (Thermo Fisher, 35-2500) was used in immunohistochemistry knockout validation on zebrafish samples at 1:150 (fig 1b), in immunohistochemistry - frozen section on human samples at 1:150 (fig s1a) and in immunohistochemistry - frozen section on mouse samples at 1:150 (fig s1b). Fluids Barriers CNS (2022) ncbi
Invitrogen
mouse monoclonal (4C3C2)
  • immunohistochemistry knockout validation; mouse; 1:100; loading ...; fig 7a
Invitrogen Cldn5 antibody (Life Technologies, 35-2500) was used in immunohistochemistry knockout validation on mouse samples at 1:100 (fig 7a). elife (2021) ncbi
Invitrogen
mouse monoclonal (4C3C2)
  • immunohistochemistry knockout validation; zebrafish ; 1:150; loading ...; fig 1b
  • immunohistochemistry - frozen section; human; 1:150; loading ...; fig s1a
  • immunohistochemistry - frozen section; mouse; 1:150; loading ...; fig s1b
Invitrogen Cldn5 antibody (Thermo Fisher, 35-2500) was used in immunohistochemistry knockout validation on zebrafish samples at 1:150 (fig 1b), in immunohistochemistry - frozen section on human samples at 1:150 (fig s1a) and in immunohistochemistry - frozen section on mouse samples at 1:150 (fig s1b). Fluids Barriers CNS (2022) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig s8a
Invitrogen Cldn5 antibody (ThermoFisher, 352588) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig s8a). Proc Natl Acad Sci U S A (2022) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 3a
Invitrogen Cldn5 antibody (Thermo Fisher, 35-2500) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3a). Brain Commun (2022) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; rat; 1:200; loading ...; fig s2d
Invitrogen Cldn5 antibody (Thermo Fisher, 35-2500) was used in immunohistochemistry on rat samples at 1:200 (fig s2d). Cell Rep Med (2022) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry knockout validation; mouse; 1:100; loading ...; fig 7a
Invitrogen Cldn5 antibody (Life Technologies, 35-2500) was used in immunohistochemistry knockout validation on mouse samples at 1:100 (fig 7a). elife (2021) ncbi
mouse monoclonal (4C3C2)
  • western blot; rat; 1:5000; loading ...; fig 4c
  • immunohistochemistry; African green monkey; 1:100; fig 1c
  • western blot; African green monkey; 1:5000; loading ...; fig 4c
Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in western blot on rat samples at 1:5000 (fig 4c), in immunohistochemistry on African green monkey samples at 1:100 (fig 1c) and in western blot on African green monkey samples at 1:5000 (fig 4c). Pharmaceutics (2021) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; dogs; 1:200; loading ...; fig 2b
Invitrogen Cldn5 antibody (Zymed, 4C3C2) was used in immunohistochemistry - paraffin section on dogs samples at 1:200 (fig 2b). Animals (Basel) (2021) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; human; loading ...; fig 1c
Invitrogen Cldn5 antibody (Thermofisher, 352,588) was used in immunohistochemistry on human samples (fig 1c). Acta Neuropathol Commun (2021) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; loading ...; fig 1d
Invitrogen Cldn5 antibody (Life technology, 35-2500) was used in immunohistochemistry on mouse samples (fig 1d). Cell Metab (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 3a
Invitrogen Cldn5 antibody (Invitrogen, 34-1600) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3a). Nat Commun (2021) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; zebrafish ; 1:500; loading ...; fig 1d
Invitrogen Cldn5 antibody (Thermo Fisher, 35-2500) was used in immunohistochemistry on zebrafish samples at 1:500 (fig 1d). elife (2021) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; 1:200; loading ...; fig s2-1c
Invitrogen Cldn5 antibody (Invitrogen Alexa fluor 488-conjugated, 352588) was used in immunohistochemistry on mouse samples at 1:200 (fig s2-1c). elife (2020) ncbi
mouse monoclonal (4C3C2)
  • ELISA; human; 1:1000
Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in ELISA on human samples at 1:1000. Alzheimers Dement (2020) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 8e
Invitrogen Cldn5 antibody (Invitrogen, 352500) was used in immunohistochemistry on mouse samples at 1:200 (fig 8e). Acta Neuropathol (2020) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; human; 1:200; loading ...; fig 3c
Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in immunohistochemistry on human samples at 1:200 (fig 3c). Science (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig 5e
  • western blot; mouse; fig 4f
Invitrogen Cldn5 antibody (Invitrogen, 34-1600) was used in immunohistochemistry on mouse samples (fig 5e) and in western blot on mouse samples (fig 4f). PLoS ONE (2020) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 5e
Invitrogen Cldn5 antibody (Invitrogen, 352588) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 5e). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 2e, 2h
Invitrogen Cldn5 antibody (Invitrogen, 34?\1600) was used in western blot on mouse samples at 1:1000 (fig 2e, 2h). CNS Neurosci Ther (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig s3g
Invitrogen Cldn5 antibody (Thermo Fisher Scientific, 34-1600) was used in immunohistochemistry on mouse samples at 1:100 (fig s3g). Nat Commun (2019) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; 1:400; loading ...; fig 1a
Invitrogen Cldn5 antibody (Thermo Fisher, 352588) was used in immunohistochemistry on mouse samples at 1:400 (fig 1a). elife (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 3b
Invitrogen Cldn5 antibody (Thermo Fisher Scientific, 341600) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3b). elife (2019) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; loading ...; fig 1b
Invitrogen Cldn5 antibody (Thermo Fisher, 352588) was used in immunohistochemistry on mouse samples (fig 1b). elife (2019) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; fig 1d
Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in immunohistochemistry on mouse samples (fig 1d). Front Physiol (2019) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 1j
Invitrogen Cldn5 antibody (Thermo Fisher Scientific, 352588) was used in immunohistochemistry on mouse samples at 1:200 (fig 1j). Nat Neurosci (2018) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; human; fig 1h
Invitrogen Cldn5 antibody (Thermo Fisher Scientific, 35-2500) was used in immunocytochemistry on human samples (fig 1h). Fluids Barriers CNS (2018) ncbi
mouse monoclonal (4C3C2)
  • western blot; rat; fig 2a
Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in western blot on rat samples (fig 2a). J Neurosci (2018) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; loading ...; fig 3h
Invitrogen Cldn5 antibody (Thermo Fisher Scientific, 352588) was used in immunohistochemistry on mouse samples (fig 3h). J Clin Invest (2017) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; loading ...; fig 3g
Invitrogen Cldn5 antibody (Thermo Fisher Scientific, 352588) was used in immunohistochemistry on mouse samples (fig 3g). Neuron (2017) ncbi
mouse monoclonal (4C3C2)
  • western blot; mouse; 1:800; loading ...; fig 4g, 4i
Invitrogen Cldn5 antibody (Invitrogen, 352500) was used in western blot on mouse samples at 1:800 (fig 4g, 4i). Neuroscience (2018) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; mouse; 1:300; loading ...; fig 6k
In order to investigate the regulation of blood-brain barrier permeability by lipid transport-dependent suppression of caveolae-mediated transcytosis, Invitrogen Cldn5 antibody (Thermo Fisher Scientific, 352588) was used in immunohistochemistry - frozen section on mouse samples at 1:300 (fig 6k). Neuron (2017) ncbi
mouse monoclonal (4C3C2)
  • western blot; mouse; 1:5000; loading ...; fig 3b
In order to describe a role for sphingosine 1-phosphate receptor-1 in regulating blood brain barrier permeability, Invitrogen Cldn5 antibody (Invitrogen, 35-3500) was used in western blot on mouse samples at 1:5000 (fig 3b). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 5b
In order to show that parasite-specific CD8 positive T cell-induced fatal vascular breakdown and subsequent neuronal death in an animal model of cerebral malaria, Invitrogen Cldn5 antibody (Thermo Fisher Scientific, 4C3C2) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 5b). PLoS Pathog (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:500; loading ...; tbl 1
In order to report the relationship between pre-tumor cells and their surrounding stroma in cerebellar tumor medulloblastoma, Invitrogen Cldn5 antibody (Thermo Fisher, 34-1600) was used in immunohistochemistry on mouse samples at 1:500 (tbl 1). elife (2016) ncbi
mouse monoclonal (4C3C2)
  • western blot; mouse; 1:500; loading ...; fig 7d
In order to report the effects of peroxisome proliferator-activated receptor beta/delta agonist on the acute phase response after brain injury, Invitrogen Cldn5 antibody (Invitrogen, 4C3C2) was used in western blot on mouse samples at 1:500 (fig 7d). Transl Res (2017) ncbi
mouse monoclonal (4C3C2)
  • western blot; mouse; 1:500; loading ...
In order to examine the function of pericyte-derived laminin in vascular integrity, Invitrogen Cldn5 antibody (Thermo, 35-2500) was used in western blot on mouse samples at 1:500. Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:400; loading ...; fig 6c
In order to examine the function of pericyte-derived laminin in vascular integrity, Invitrogen Cldn5 antibody (Invitrogen, 34-1600) was used in immunohistochemistry on mouse samples at 1:400 (fig 6c). Sci Rep (2016) ncbi
mouse monoclonal (4C3C2)
  • western blot; rat; 1:500; loading ...; fig 6c
In order to elucidate the mechanisms by which hypertonic saline attenuates cerebral oedema, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in western blot on rat samples at 1:500 (fig 6c). BMC Neurosci (2016) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; rat; 1:100; loading ...; fig 3c
In order to assess the effects of PEGylation on the toxicity of nanoparticles in rat brains, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in immunocytochemistry on rat samples at 1:100 (fig 3c). Mol Pharm (2016) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; mouse; fig s1
In order to ask if nucleoside diphosphate kinase B interacting with caveolin-1 in endothelial cells is required for the regulation of angiogenesis and adherens junction integrity, Invitrogen Cldn5 antibody (Thermofisher Scientific, 35-2500) was used in immunocytochemistry on mouse samples (fig s1). J Cereb Blood Flow Metab (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; fig s2
In order to investigate the effects of TNF treatment and SFK activation using human dermal microvascular endothelial cells, Invitrogen Cldn5 antibody (Life Technologies, 34-1600) was used in immunocytochemistry on human samples (fig s2). PLoS ONE (2016) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; dogs; 1:200; loading ...; fig 2d
  • western blot; dogs; 1:1000; loading ...; fig 1h
In order to measure tight junction protein expression in canine duodenum, lung, liver, and kidney, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in immunohistochemistry - paraffin section on dogs samples at 1:200 (fig 2d) and in western blot on dogs samples at 1:1000 (fig 1h). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 2b
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 2i
In order to study the role of endothelial cell exocytosis in cerebral cavernous malformation disease progression, Invitrogen Cldn5 antibody (Invitrogen, 34-1600) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2b) and in immunohistochemistry - frozen section on human samples at 1:100 (fig 2i). Nat Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
In order to assess the effect of polyinosinic-polycytidylic acid on the barrier function and tight junction integrity of primary human lung microvascular endothelial cells, Invitrogen Cldn5 antibody (Invitrogen, 34-1600) was used in western blot on human samples (fig 3). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 3a
In order to test if hypoxia inducible factor-1 activation contributes to hyperglycemia-aggravated blood brain barrier disruption in an ischemic stroke model, Invitrogen Cldn5 antibody (Invitrogen, 34-1600) was used in western blot on mouse samples (fig 3a). Neurobiol Dis (2016) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; human; 1:50; fig 2e
In order to examine trafficking of cancer-targeting alkylphosphocholine analogues across the blood brain barrier, Invitrogen Cldn5 antibody (Invitrogen, 4C3C2) was used in immunocytochemistry on human samples at 1:50 (fig 2e). Mol Pharm (2016) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; rat; 1:50; loading ...; fig 1d
  • western blot; rat; 1:500; loading ...; fig 3b
In order to elucidate how miR-21-5p alleviates traumatic brain injury in rats, Invitrogen Cldn5 antibody (Thermo Scientific, 35-2500) was used in immunohistochemistry on rat samples at 1:50 (fig 1d) and in western blot on rat samples at 1:500 (fig 3b). Brain Res (2016) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 2
In order to perform an immunohistochemical analysis on 25 cases of littoral cell angioma, Invitrogen Cldn5 antibody (Invitrogen, 4C3C2) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Histopathology (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - free floating section; mouse; 1:500; fig s2
In order to characterize dysregulation of neuronal network activity following a stroke due to microglia protecting against brain injury and their selective elimination, Invitrogen Cldn5 antibody (Invitrogen, 34-1600) was used in immunohistochemistry - free floating section on mouse samples at 1:500 (fig s2). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:50; fig 4
  • western blot; human; 1:500; fig 4
In order to study the prevention of amyloid-beta induced blood-brain barrier disruption and endothelial cell dysfunction by targeting Endophilin-1 by MicroRNA-107, Invitrogen Cldn5 antibody (Thermo Scientific, 34-1600) was used in immunocytochemistry on human samples at 1:50 (fig 4) and in western blot on human samples at 1:500 (fig 4). Exp Cell Res (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; domestic horse; fig 5
  • western blot; domestic horse; 1:1000; fig 1
In order to compare expression levels and distribution of Claudin-1, 2, 4, and 5 in equine tissues, Invitrogen Cldn5 antibody (Invitrogen, 34-1600) was used in immunohistochemistry - paraffin section on domestic horse samples (fig 5) and in western blot on domestic horse samples at 1:1000 (fig 1). J Vet Sci (2016) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; mouse; fig 1
In order to determine the induction by vascular endothelial growth factor A (VEGF-A) due to ectodomain shedding of lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1), Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in immunohistochemistry - frozen section on mouse samples (fig 1). J Biol Chem (2016) ncbi
mouse monoclonal (4C3C2)
  • western blot; mouse; 1:500; fig 5
In order to determine the rescue of VE-PTP-dependent restoration of Tie2 signaling from angiopoietin-2-induced blood-brain barrier compromise and increased stroke size, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in western blot on mouse samples at 1:500 (fig 5). Acta Neuropathol (2016) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; human; fig 4
In order to study a model of the human blood-brain barrier in 3D to analyze astrocyte/endothelial interactions and transport of nanoparticles, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in immunocytochemistry on human samples (fig 4). F1000Res (2015) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:400; fig 4
In order to study the neuroprotective effects of olaparib, a poly(ADP-ribose) polymerase inhibitor, in transient cerebral ischemia, Invitrogen Cldn5 antibody (Invitrogen, 34-1600) was used in immunohistochemistry - frozen section on mouse samples at 1:400 (fig 4). Neurochem Res (2016) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; human; loading ...; fig 3c
  • western blot; human; loading ...; fig 3a
In order to determine the role of cingulin in the barrier function of endothelial cells, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in immunocytochemistry on human samples (fig 3c) and in western blot on human samples (fig 3a). Arterioscler Thromb Vasc Biol (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:500; fig 5
In order to evaluate endothelial MyD88 and the vagus nerve for blood-brain barrier deterioration and hippocampal gene expression in polymicrobial sepsis, Invitrogen Cldn5 antibody (Invitrogen, 341600) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 5). PLoS ONE (2016) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; human; fig 1
  • immunohistochemistry; mouse; fig 1
In order to study how acceleration of ALS neurodegeneration is caused by presymptomatic activation of the PDGF-CC pathway, Invitrogen Cldn5 antibody (Thermo Fisher, 352588) was used in immunohistochemistry on human samples (fig 1) and in immunohistochemistry on mouse samples (fig 1). Acta Neuropathol (2016) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; fig 5
In order to determine the roles of Sox7, Sox17, and Sox18 in the developing and mature mouse vasculature, Invitrogen Cldn5 antibody (Invitrogen, 352588) was used in immunohistochemistry on mouse samples (fig 5). PLoS ONE (2015) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; tiger salamander; 1:500; fig 1
In order to characterize axolotl spinal cord regeneration and how induction of neural stem cell expansion occurs by planar cell polarity-mediation, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in immunohistochemistry on tiger salamander samples at 1:500 (fig 1). elife (2015) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; human; 1:50; fig 2
In order to describe methods to differentiate and characterize hPSC-derived brain microvascular endothelial cells, Invitrogen Cldn5 antibody (Invitrogen, 4C3C2) was used in immunocytochemistry on human samples at 1:50 (fig 2). Methods (2016) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; 1:50
In order to study the effects of Abeta on the functionality of the blood-CSF barrier, Invitrogen Cldn5 antibody (Life Technologies, 35-2500) was used in immunohistochemistry on mouse samples at 1:50. J Neurosci (2015) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; human; 1:50
  • western blot; human; 1:250
In order to elucidate the effects and mechanism of miR-18a on the permeability of the blood-tumor barrier, Invitrogen Cldn5 antibody (Life Technologies, 35-2500) was used in immunocytochemistry on human samples at 1:50 and in western blot on human samples at 1:250. J Neurosci Res (2015) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; mouse; 1:50; fig 1
In order to determine how traumatic brain injury causes rapid pericyte loss and then reactive pericytosis in the cerebral cortex, Invitrogen Cldn5 antibody (Life technologies, 35-2500) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (4C3C2)
  • western blot; human; 0.5 ug/ml
In order to test if claudin 3 plays an instigating and/or a functional role in the urothelial tight junctions, Invitrogen Cldn5 antibody (Life Technologies, 4C3C2) was used in western blot on human samples at 0.5 ug/ml. Bladder (San Franc) (2015) ncbi
mouse monoclonal (4C3C2)
  • western blot; rat; 1:500
In order to test if 2,3,5,6-tetramethylpyrazine protects the blood brain barries integrity in ischemia/reperfusion injury, Invitrogen Cldn5 antibody (Invitrogen Life Technologies, 4C3C2) was used in western blot on rat samples at 1:500. Exp Ther Med (2015) ncbi
domestic rabbit polyclonal
In order to determine the role of lncRNAs in blood tumor barrier permeability, Invitrogen Cldn5 antibody (Zymed, 34-1600) was used . Oncotarget (2015) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; mouse
In order to evaluate capacitance sensor array for the estimation of paracellular permeability of cerebral endothelial cells, Invitrogen Cldn5 antibody (Invitrogen, 352588) was used in immunocytochemistry on mouse samples . Sci Rep (2015) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; mouse; 1:200; fig e5
In order to investigate the mechanisms that regulate the entrance and exit of immune cells from the central nervous system, Invitrogen Cldn5 antibody (Molecular Probes, 352588) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig e5). Nature (2015) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; mouse; 1:500
In order to examine the effects of nicotine on carrier-mediated glucose transport into ischemic brain, Invitrogen Cldn5 antibody (Life Technologies, 35-2500) was used in immunohistochemistry - frozen section on mouse samples at 1:500. Fluids Barriers CNS (2015) ncbi
domestic rabbit polyclonal
In order to investigate the role of claudin-1/claudin-5 in epithelial/endothelial barriers, Invitrogen Cldn5 antibody (Life Technologies, 34-1600) was used . Biomaterials (2015) ncbi
mouse monoclonal (4C3C2)
  • western blot; human
In order to evaluate the effect of tumor necrosis factor on claudin-5 endothelial tight junction barriers, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in western blot on human samples . PLoS ONE (2015) ncbi
domestic rabbit polyclonal
In order to evaluate the effect of tumor necrosis factor on claudin-5 endothelial tight junction barriers, Invitrogen Cldn5 antibody (Invitrogen, 34-1600) was used . PLoS ONE (2015) ncbi
mouse monoclonal (4C3C2)
  • western blot; human; 1:300-500
In order to elucidate the role of Nrf2 at the blood brain barrier, Invitrogen Cldn5 antibody (Invitrogen, #35-2500) was used in western blot on human samples at 1:300-500. PLoS ONE (2015) ncbi
mouse monoclonal (4C3C2)
  • western blot; mouse; 1:1000
In order to investigate the effect of prostacyclin on pericyte loss and demyelination induced by lysophosphatidylcholine in the central nervous system, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in western blot on mouse samples at 1:1000. J Biol Chem (2015) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; rat; 2 ug/ml
In order to investigate cerebrospinal fluid circulatory system during rat development, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in immunohistochemistry on rat samples at 2 ug/ml. Fluids Barriers CNS (2015) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; black-tailed prairie dog; 1:100
Invitrogen Cldn5 antibody (Invitrogen, 4C3C2) was used in immunohistochemistry on black-tailed prairie dog samples at 1:100. Vet Ophthalmol (2016) ncbi
domestic rabbit polyclonal
In order to study the role of astroglial cx43 in immune quiescence of the brain, Invitrogen Cldn5 antibody (Invitrogen, 34-1600) was used . J Neurosci (2015) ncbi
domestic rabbit polyclonal
In order to investigate the role of LSR/angulin-1 in blood-brain barrier formation, Invitrogen Cldn5 antibody (Invitrogen, 34-1600) was used . J Cell Biol (2015) ncbi
domestic rabbit polyclonal
In order to evaluate an animal model for periventricular leukomalacia, Invitrogen Cldn5 antibody (Zymed, 34-1600) was used . J Clin Invest (2015) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; human; 1:50
Invitrogen Cldn5 antibody (Zymed Laboratories, 4C3C2) was used in immunohistochemistry - paraffin section on human samples at 1:50. Anticancer Res (2015) ncbi
mouse monoclonal (4C3C2)
  • western blot; human; 1:2000; loading ...; fig 4a
In order to determine the effect of ANGPT1 inhibition on ovarian angiogenesis in follicular fluid from women at risk of ovarian hyperstimulation syndrome, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in western blot on human samples at 1:2000 (fig 4a). Reprod Fertil Dev (2016) ncbi
domestic rabbit polyclonal
In order to study how knockdown of Robo4 alters the blood-tumor barrier, Invitrogen Cldn5 antibody (Zymed Laboratories, 34-1600) was used . J Neuropathol Exp Neurol (2015) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; human; 1:50
  • western blot; human; 1:125
In order to show that the loss of claudin-5 in cardiomyocytes and endothelial cells is prevalent in human heart failure, Invitrogen Cldn5 antibody (Life Technologies, 35-2500) was used in immunohistochemistry on human samples at 1:50 and in western blot on human samples at 1:125. Cardiovasc Pathol (2015) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse
In order to investigate the relationship between hypoxia response and Norrin/Frizzled4 signaling during retinal vascular development, Invitrogen Cldn5 antibody (Invitrogen, 352588) was used in immunohistochemistry on mouse samples . Invest Ophthalmol Vis Sci (2014) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; 1:300; fig 4
  • western blot; mouse; 1:1000
In order to study the blood-brain barrier function in germ free mice, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in immunohistochemistry on mouse samples at 1:300 (fig 4) and in western blot on mouse samples at 1:1000. Sci Transl Med (2014) ncbi
mouse monoclonal (4C3C2)
In order to examine the role of perforin and CD8 T cells in immune-mediated blood-brain barrier disruption, Invitrogen Cldn5 antibody (Invitrogen, 35-C2500) was used . PLoS ONE (2014) ncbi
mouse monoclonal (4C3C2)
  • western blot; human
In order to study tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in western blot on human samples . Surg Obes Relat Dis (2015) ncbi
mouse monoclonal (4C3C2)
In order to investigate the effect of C1-Inhibitor treatment in a model of traumatic brain injury, Invitrogen Cldn5 antibody (Invitrogen, 35?C2500) was used . Front Cell Neurosci (2014) ncbi
mouse monoclonal (4C3C2)
  • western blot; rat; 1:2000; fig 6
In order to study the role of vascular endothelial growth factor A in ovarian hyperstimulation syndrome, Invitrogen Cldn5 antibody (Invitrogen Corp., 35-2500) was used in western blot on rat samples at 1:2000 (fig 6). J Steroid Biochem Mol Biol (2014) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; fig 3
In order to elucidate the contribution of canonical Wnt pathway members to the vascular development of the central nervous system and in the specification of the blood-brain barrier and blood-retina barrier, Invitrogen Cldn5 antibody (Invitrogen, 352588) was used in immunohistochemistry on mouse samples (fig 3). J Clin Invest (2014) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1e
In order to correlate claudin 1-5 and 7 expression with the survival, grade, and stage of patients with renal cell cancer, Invitrogen Cldn5 antibody (Zymed, 4C3C2) was used in immunohistochemistry - paraffin section on human samples (fig 1e). Anticancer Res (2014) ncbi
mouse monoclonal (4C3C2)
  • western blot; rat; 1:300
Invitrogen Cldn5 antibody (Invitrogen, 4C3C2) was used in western blot on rat samples at 1:300. Microcirculation (2014) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; human
In order to evaluate an in vitro blood-brain barrier model, Invitrogen Cldn5 antibody (Zymed Laboratories, 35-2500) was used in immunocytochemistry on human samples . J Neurosci Methods (2014) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; mouse; 1:400
In order to identify mechanisms governing the establishment of a functional blood brain barrier, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in immunohistochemistry - frozen section on mouse samples at 1:400. Nature (2014) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; human; 1:150
  • western blot; human; 1:350
In order to test the effect of hypo and hyperglycemic conditions on blood brain barrier integrity and endothelial function in vitro, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in immunocytochemistry on human samples at 1:150 and in western blot on human samples at 1:350. Fluids Barriers CNS (2014) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; mouse; 1:50
In order to describe a murine blood-brain barrier coculture model that includes neurons, astrocytes, and brain endothelial cells, Invitrogen Cldn5 antibody (Life technologies, 35-2500) was used in immunocytochemistry on mouse samples at 1:50. Methods Mol Biol (2014) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; mouse; 1:50; tbl 1
In order to analyze why the blood-brain barrier breakdown occurs via oxidative stress-dependent tight junction protein disruption following moderate hypoxia and reoxygenation, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in immunocytochemistry on mouse samples at 1:50 (tbl 1). PLoS ONE (2013) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; 1:50; fig 1
In order to assess the role of pericytes in pathophysiological processes of the developing cortex, Invitrogen Cldn5 antibody (Life Technologies Corporation, 35-2500) was used in immunohistochemistry on mouse samples at 1:50 (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (4C3C2)
  • western blot; rat; 1:1000
In order to evaluate the neuroprotective effect of the lipoxin A4 receptor agonist, BML-111, in a rat model of ischemic stroke, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in western blot on rat samples at 1:1000. J Neurochem (2014) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; rat
  • western blot; rat; 1:500
In order to evaluate protocols for the isolation and culture of endothelial cells from rate brain and spinal cord, Invitrogen Cldn5 antibody (Life Technologies, 35-2500) was used in immunocytochemistry on rat samples and in western blot on rat samples at 1:500. BMC Neurosci (2013) ncbi
mouse monoclonal (4C3C2)
  • western blot; mouse
In order to study the role of endothelial-to-mesenchymal transition in the onset and progression of cerebral cavernous malformations, Invitrogen Cldn5 antibody (Invitrogen, 352588) was used in western blot on mouse samples . Nature (2013) ncbi
mouse monoclonal (4C3C2)
  • western blot; domestic sheep; 1:5000; fig 2
In order to examine the photoperiodically different concentration of polychlorinated biphenyls in the cerebrospinal fluid in sheep, Invitrogen Cldn5 antibody (Invitrogen, 4C3C2) was used in western blot on domestic sheep samples at 1:5000 (fig 2). Neurotoxicol Teratol (2013) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 1b
In order to evaluate the impact of claudin expression in grade I-III ependymomas, Invitrogen Cldn5 antibody (Zymed, 4C3C2) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1b). Histol Histopathol (2013) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; human; fig 4
In order to discuss factors that regulate the blood brain barrier, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in immunohistochemistry - paraffin section on human samples (fig 4). Mol Pharm (2013) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to examine tight junction and adherens junction proteins in normal human lung, IPF, cryptogenic organizing pneumonia, and asbestosis, Invitrogen Cldn5 antibody (Zymed, 4C3C2) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Hum Pathol (2013) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; fig S3
In order to investigate the role of Norrin in retinal vascular development, Invitrogen Cldn5 antibody (Invitrogen, 352588) was used in immunohistochemistry on mouse samples (fig S3). Cell (2012) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; human; 1:200
  • western blot; human; 1:1000
In order to report that endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability, Invitrogen Cldn5 antibody (Zymed Laboratories, 35-2500) was used in immunocytochemistry on human samples at 1:200 and in western blot on human samples at 1:1000. Vasc Cell (2012) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; rat; 1.25 ug/ml
  • western blot; rat; 1 ug/ml; fig 2, 3
  • immunohistochemistry - paraffin section; human; 2.5 ug/ml; fig 2, 3
In order to identify different claudins in the choroid plexuses of developing and adult rats, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in immunohistochemistry - frozen section on rat samples at 1.25 ug/ml, in western blot on rat samples at 1 ug/ml (fig 2, 3) and in immunohistochemistry - paraffin section on human samples at 2.5 ug/ml (fig 2, 3). Histochem Cell Biol (2012) ncbi
mouse monoclonal (4C3C2)
  • western blot; rat; 1:500; fig 2
In order to assess the role of neuroinflammation in mediating the effects of chronic stress exposure and/or methamphetamine on blood brain barrier structure and function, Invitrogen Cldn5 antibody (Invitrogen, 352500) was used in western blot on rat samples at 1:500 (fig 2). J Neuroimmune Pharmacol (2012) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; mouse; fig 4
In order to determine the contribution of neutrophils to central nervous system vascular permeability, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in immunocytochemistry on mouse samples (fig 4). J Immunol (2012) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; rat; 1:50; fig 2
  • western blot; rat; 1:250; fig 2
In order to use Phoneutria nigriventer spider venom to study the blood brain barrier, Invitrogen Cldn5 antibody (Zymed, 352500) was used in immunohistochemistry - frozen section on rat samples at 1:50 (fig 2) and in western blot on rat samples at 1:250 (fig 2). Neurochem Res (2012) ncbi
mouse monoclonal (4C3C2)
  • western blot; mouse; 1:100; fig 2
In order to test if claudin-5 modulation is sufficient to prevent the onset of heart failure, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in western blot on mouse samples at 1:100 (fig 2). Mol Ther (2012) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; rat; fig 6
In order to study the junctional complexes of liver sinusoidal endothelial cells, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in immunohistochemistry on rat samples (fig 6). PLoS ONE (2012) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; human; 1:100
  • western blot; human; 1:1000
In order to assess the role of tight junctions and gap proteins in cervical remodeling, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in immunohistochemistry - frozen section on human samples at 1:100 and in western blot on human samples at 1:1000. J Transl Med (2012) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to ascertain the expression of claudin 1, 3M, 3S, 4, 5, and 7 in vulvar epithelial neoplasia and compare their expression in samples with invasive vulvar squamous cell carcinoma, Invitrogen Cldn5 antibody (Zymed, 4C3C2) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Tumour Biol (2012) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; human; fig 1
In order to investigate how Neisseria meningitidis affects epithelial and endothelial cells differently, Invitrogen Cldn5 antibody (Zymed, 4C3C2) was used in immunocytochemistry on human samples (fig 1). Infect Immun (2012) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; mouse; tbl 1
In order to assess the effects of stabilizing the blood brain barrier function by therapeutic targeting tight junction proteins for experimental autoimmune encephalomyelitis, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in immunohistochemistry - frozen section on mouse samples (tbl 1). Acta Neuropathol (2011) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; human; fig 1
In order to assess claudin-5 expression in human mesenchymal tumors, Invitrogen Cldn5 antibody (Invitrogen, 4C3C2) was used in immunohistochemistry on human samples (fig 1). Am J Surg Pathol (2011) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; human; 1:150; fig 1
  • western blot; human; 1:500; fig 2
In order to examine the function and location of tight junction proteins in immune cells, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in immunocytochemistry on human samples at 1:150 (fig 1) and in western blot on human samples at 1:500 (fig 2). J Cell Mol Med (2012) ncbi
mouse monoclonal (4C3C2)
  • western blot; domestic sheep; 1:5000; fig 1
In order to compare the tight junction proteins in the choroid plexus of ewes exposed to short or long days, Invitrogen Cldn5 antibody (Invitrogen, 4C3C2) was used in western blot on domestic sheep samples at 1:5000 (fig 1). Brain Res (2011) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; pigs ; 1:200; fig 1
In order to determine the impact of acute cerebral ischemia on tight junction protein arrangement and the role of caspase-3 in this process, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in immunohistochemistry on pigs samples at 1:200 (fig 1). PLoS ONE (2011) ncbi
mouse monoclonal (4C3C2)
  • western blot; pigs ; fig 1
In order to use a guinea pig exchange transfusion model to study the effects of cell-free hemoglobin, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in western blot on pigs samples (fig 1). Am J Pathol (2011) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; 10 ug/ml; fig 2
  • western blot; mouse; 0.5 ug/ml; fig 3
In order to identify and characterize claudin-5 expression in podocytes, Invitrogen Cldn5 antibody (Zymed, 4C3C2) was used in immunohistochemistry on mouse samples at 10 ug/ml (fig 2) and in western blot on mouse samples at 0.5 ug/ml (fig 3). Cell Tissue Res (2011) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; human; 1:45; fig 2
In order to discuss methods to assess blood brain barrier integrity, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in immunohistochemistry - paraffin section on human samples at 1:45 (fig 2). Methods Mol Biol (2011) ncbi
mouse monoclonal (4C3C2)
  • western blot; human; fig s4
In order to identify annexin 2 as a regulator of endothelial morphogenesis, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in western blot on human samples (fig s4). J Biol Chem (2010) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; human; fig 4
In order to report a clinical case of macular telangiectasia type 2 with perifoveal m, Invitrogen Cldn5 antibody (Invitrogen, 35?C2500) was used in immunohistochemistry on human samples (fig 4). Ophthalmology (2010) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 1
In order to correlate expression of claudin-5 to ovarian cancer behavior, Invitrogen Cldn5 antibody (Zymed, 4C3C2) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 1). Anticancer Res (2009) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; rat; 1:100; fig 8
In order to test if glial dysfunction is a major contributor to the blood-retinal barrier, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in immunohistochemistry on rat samples at 1:100 (fig 8). J Neurosci Res (2010) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; 1:100; fig 2
  • western blot; mouse; 1:250-1:500; fig 1
In order to examine the effect of prolonged hypoxia on blood-brain barrier integrity in vivo, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in immunohistochemistry on mouse samples at 1:100 (fig 2) and in western blot on mouse samples at 1:250-1:500 (fig 1). J Cereb Blood Flow Metab (2010) ncbi
mouse monoclonal (4C3C2)
  • western blot; rat; fig 4
In order to examine the inflammatory and molecular changes that occur within the bladder uroepithelium using a spinal contusion injury model, Invitrogen Cldn5 antibody (Invitrogen, 35-2500) was used in western blot on rat samples (fig 4). J Neurotrauma (2010) ncbi
mouse monoclonal (4C3C2)
  • western blot; domestic sheep; 1:5000; fig 2c
In order to measure the expression of tight junction proteins in the cerebral cortex, cerebellum, and spinal cord of fetuses after maternal treatment with dexamethasone, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in western blot on domestic sheep samples at 1:5000 (fig 2c). Am J Physiol Heart Circ Physiol (2010) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; mouse; 1:100; fig 4
In order to study the role of ischemia in inducing sustained contraction of pericytes on microvessels in the intact mouse brain, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in immunohistochemistry on mouse samples at 1:100 (fig 4). Nat Med (2009) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 4
In order to test if Golgi-associated cPLA2alpha contributes to trafficking of junction proteins, Invitrogen Cldn5 antibody (Zymed Laboratories, 35-2500) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 4). Mol Biol Cell (2009) ncbi
mouse monoclonal (4C3C2)
  • western blot; rat; 1:1000
In order to test if pre-treatment with nitric oxide before ischemia and reperfusion injury affects cell junction proteins and vascular endothelial growth factor, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in western blot on rat samples at 1:1000. J Surg Res (2009) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; human; 1:100; fig 1
In order to study the expression of adherens junction and tight junction components in human peripheral nerve endoneurium, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 1). J Histochem Cytochem (2009) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1e
In order to report the expression of various claudins in patients with sarcoidosis, usual interstitial pneumonia, and normal human lung, Invitrogen Cldn5 antibody (Zymed, 4C3C2) was used in immunohistochemistry - paraffin section on human samples (fig 1e). J Histochem Cytochem (2009) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; human; fig 3d
In order to study tight junction proteins in ECV304 cells, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in immunocytochemistry on human samples (fig 3d). Neurosci Lett (2008) ncbi
mouse monoclonal (4C3C2)
  • western blot; human; fig 2
In order to elucidate the mechanisms that direct the transformation of adherent endothelial cells to multicellular invading sprouts, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in western blot on human samples (fig 2). Am J Physiol Cell Physiol (2008) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; rat; 1:50
In order to characterize the blood brain barrier in the median eminence-arcuate nucleus complex, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in immunohistochemistry - frozen section on rat samples at 1:50. J Chem Neuroanat (2008) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; human; 20 ug/ml; tbl 1
In order to define the localization of CD81, scavenger receptor class B member I, and Claudin-1 in HCV entry of hepatocytes, Invitrogen Cldn5 antibody (Zymed, 4C3C2) was used in immunohistochemistry - paraffin section on human samples at 20 ug/ml (tbl 1). Hepatology (2008) ncbi
mouse monoclonal (4C3C2)
  • immunoprecipitation; human; fig 7
In order to identify and characterize a new type of adherens junction in human meningiomas, Invitrogen Cldn5 antibody (Zymed, 4C3C2) was used in immunoprecipitation on human samples (fig 7). Cell Tissue Res (2008) ncbi
mouse monoclonal (4C3C2)
  • immunocytochemistry; rat; 1:100; fig 1
  • western blot; rat; 1:500; fig 1
In order to test if trafficking of occludin and claudin-5 is essential for forming the tight junction seal between microvascular endothelial cells, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in immunocytochemistry on rat samples at 1:100 (fig 1) and in western blot on rat samples at 1:500 (fig 1). J Neurochem (2007) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; rat
In order to study the spatial and functional relationships between tight and adherens junctions in the sinus endothelial cells of rat spleen, Invitrogen Cldn5 antibody (Zymed Laboratories, 35-2500) was used in immunohistochemistry - frozen section on rat samples . Histochem Cell Biol (2008) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 2e
In order to determine the impact of claudins in surgically-treated esophageal carcinoma, Invitrogen Cldn5 antibody (Zymed, 4C3C2) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2e). APMIS (2007) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; human; fig 1
In order to measure the expression of tight junction proteins in human lung squamous cell carcinomas and adenocarcinomas, Invitrogen Cldn5 antibody (Invitrogen, 4C3C2) was used in immunohistochemistry on human samples (fig 1). Mod Pathol (2007) ncbi
mouse monoclonal (4C3C2)
  • western blot; rat; 1:1000; fig 3
In order to analyze lumbar spinal cord proteins present in naive and experimental autoimmune encephalomyelitis rats, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in western blot on rat samples at 1:1000 (fig 3). Neuroscience (2007) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; human; fig 1
In order to review structural proteins of epidermal tight junctions, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in immunohistochemistry - frozen section on human samples (fig 1). Br J Dermatol (2007) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 1d
In order to determine the distribution of claudins 1, 4, 5, and 7 and occludin in benign and malignant ameloblastomas and developing human teeth, Invitrogen Cldn5 antibody (Zymed, 4C3C2) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1d). J Oral Pathol Med (2007) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - paraffin section; human; 1:50
In order to observe the expression of claudins in mesothelioma and metastatic pleural adenocarcinoma, Invitrogen Cldn5 antibody (Zymed, 4C3C2) was used in immunohistochemistry - paraffin section on human samples at 1:50. J Clin Pathol (2006) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry - frozen section; human
In order to determine the distribution and role of perineurial cells in neurofibromas, Invitrogen Cldn5 antibody (ZYMED, 35-2500) was used in immunohistochemistry - frozen section on human samples . J Histochem Cytochem (2006) ncbi
mouse monoclonal (4C3C2)
  • immunohistochemistry; human; tbl 1
In order to discuss the role of tight junctions in hair cells, Invitrogen Cldn5 antibody (Zymed, 4C3C2) was used in immunohistochemistry on human samples (tbl 1). Arch Dermatol Res (2003) ncbi
mouse monoclonal (4C3C2)
  • western blot; human; fig 3
In order to study claudins in the lung, Invitrogen Cldn5 antibody (Zymed, 35-2500) was used in western blot on human samples (fig 3). Am J Respir Cell Mol Biol (2003) ncbi
Abcam
domestic rabbit polyclonal
  • western blot; mouse; 1:500; fig 6a
Abcam Cldn5 antibody (Abcam, ab15106) was used in western blot on mouse samples at 1:500 (fig 6a). Fluids Barriers CNS (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 4e
Abcam Cldn5 antibody (Abcam, ab15106) was used in western blot on mouse samples at 1:1000 (fig 4e). J Exp Med (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 7i
Abcam Cldn5 antibody (Abcam, ab15106) was used in western blot on mouse samples at 1:1000 (fig 7i). Nat Commun (2020) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 6b
Abcam Cldn5 antibody (Abcam, Ab15106) was used in western blot on rat samples (fig 6b). Biol Sex Differ (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 5d
Abcam Cldn5 antibody (Abcam, ab15106) was used in western blot on mouse samples (fig 5d). Dis Model Mech (2018) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:50; loading ...; fig 5c
In order to test if H2S and its metabolites alter endothelial permeability, Abcam Cldn5 antibody (Abcam, ab15106) was used in immunocytochemistry on human samples at 1:50 (fig 5c). Redox Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 6
Abcam Cldn5 antibody (Abcam, ab15106) was used in western blot on mouse samples (fig 6). Oncotarget (2016) ncbi
Articles Reviewed
  1. Li Y, Wang C, Zhang L, Chen B, Mo Y, Zhang J. Claudin-5a is essential for the functional formation of both zebrafish blood-brain barrier and blood-cerebrospinal fluid barrier. Fluids Barriers CNS. 2022;19:40 pubmed publisher
  2. Zhao Q, Dai W, Chen H, Jacobs R, Zlokovic B, Lund B, et al. Prenatal disruption of blood-brain barrier formation via cyclooxygenase activation leads to lifelong brain inflammation. Proc Natl Acad Sci U S A. 2022;119:e2113310119 pubmed publisher
  3. Faulhaber L, Phuong A, Hartsuyker K, Cho Y, Mand K, Harper S, et al. Brain capillary obstruction during neurotoxicity in a mouse model of anti-CD19 chimeric antigen receptor T-cell therapy. Brain Commun. 2022;4:fcab309 pubmed publisher
  4. Chang J, Greene C, Frudd K, Araujo Dos Santos L, Futter C, Nichols B, et al. Methamphetamine enhances caveolar transport of therapeutic agents across the rodent blood-brain barrier. Cell Rep Med. 2022;3:100497 pubmed publisher
  5. Sasson E, Anzi S, Bell B, Yakovian O, Zorsky M, Deutsch U, et al. Nano-scale architecture of blood-brain barrier tight-junctions. elife. 2021;10: pubmed publisher
  6. Watanabe D, Nakagawa S, Morofuji Y, Tóth A, Vastag M, Aruga J, et al. Characterization of a Primate Blood-Brain Barrier Co-Culture Model Prepared from Primary Brain Endothelial Cells, Pericytes and Astrocytes. Pharmaceutics. 2021;13: pubmed publisher
  7. He W, Lu Q, Sherchan P, Huang L, Hu X, Zhang J, et al. Activation of Frizzled-7 attenuates blood-brain barrier disruption through Dvl/β-catenin/WISP1 signaling pathway after intracerebral hemorrhage in mice. Fluids Barriers CNS. 2021;18:44 pubmed publisher
  8. Rozolen J, Teodoro T, Sobral R, Sueiro F, Laufer Amorim R, Elias F, et al. Investigation of Prognostic Value of Claudin-5, PSMA, and Ki67 Expression in Canine Splenic Hemangiosarcoma. Animals (Basel). 2021;11: pubmed publisher
  9. Wei X, Meel M, Breur M, Bugiani M, Hulleman E, Phoenix T. Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas. Acta Neuropathol Commun. 2021;9:142 pubmed publisher
  10. Gruber T, Pan C, Contreras R, Wiedemann T, Morgan D, Skowronski A, et al. Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension. Cell Metab. 2021;33:1155-1170.e10 pubmed publisher
  11. Nikolakopoulou A, Wang Y, Ma Q, Sagare A, Montagne A, Huuskonen M, et al. Endothelial LRP1 protects against neurodegeneration by blocking cyclophilin A. J Exp Med. 2021;218: pubmed publisher
  12. Zhou H, Qin L, Jiang Q, Murray K, Zhang H, Li B, et al. Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model. Nat Commun. 2021;12:504 pubmed publisher
  13. Parab S, Quick R, Matsuoka R. Endothelial cell-type-specific molecular requirements for angiogenesis drive fenestrated vessel development in the brain. elife. 2021;10: pubmed publisher
  14. Orsenigo F, Conze L, Jauhiainen S, Corada M, Lazzaroni F, Malinverno M, et al. Mapping endothelial-cell diversity in cerebral cavernous malformations at single-cell resolution. elife. 2020;9: pubmed publisher
  15. Liu C, Yamazaki Y, Heckman M, Martens Y, Jia L, Yamazaki A, et al. Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer's disease. Alzheimers Dement. 2020;16:1372-1383 pubmed publisher
  16. Devraj G, Guérit S, Seele J, Spitzer D, Macas J, Khel M, et al. HIF-1α is involved in blood-brain barrier dysfunction and paracellular migration of bacteria in pneumococcal meningitis. Acta Neuropathol. 2020;140:183-208 pubmed publisher
  17. Pellegrini L, Bonfio C, Chadwick J, Begum F, Skehel M, Lancaster M. Human CNS barrier-forming organoids with cerebrospinal fluid production. Science. 2020;: pubmed publisher
  18. Peroutka R, Buzza M, Mukhopadhyay S, Johnson T, Driesbaugh K, Antalis T. Testisin/Prss21 deficiency causes increased vascular permeability and a hemorrhagic phenotype during luteal angiogenesis. PLoS ONE. 2020;15:e0234407 pubmed publisher
  19. Kang L, Yu H, Yang X, Zhu Y, Bai X, Wang R, et al. Neutrophil extracellular traps released by neutrophils impair revascularization and vascular remodeling after stroke. Nat Commun. 2020;11:2488 pubmed publisher
  20. Rafikova O, James J, Eccles C, Kurdyukov S, Niihori M, Varghese M, et al. Early progression of pulmonary hypertension in the monocrotaline model in males is associated with increased lung permeability. Biol Sex Differ. 2020;11:11 pubmed publisher
  21. Engelbrecht E, Lévesque M, He L, Vanlandewijck M, Nitzsche A, Niazi H, et al. Sphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aorta. elife. 2020;9: pubmed publisher
  22. Li C, Chen W, Wang J, Xia M, Jia Z, Guo C, et al. Nicotinamide riboside rescues angiotensin II-induced cerebral small vessel disease in mice. CNS Neurosci Ther. 2020;26:438-447 pubmed publisher
  23. Diéguez Hurtado R, Kato K, Giaimo B, Nieminen Kelhä M, Arf H, Ferrante F, et al. Loss of the transcription factor RBPJ induces disease-promoting properties in brain pericytes. Nat Commun. 2019;10:2817 pubmed publisher
  24. Cho C, Wang Y, Smallwood P, Williams J, Nathans J. Dlg1 activates beta-catenin signaling to regulate retinal angiogenesis and the blood-retina and blood-brain barriers. elife. 2019;8: pubmed publisher
  25. Benz F, Wichitnaowarat V, Lehmann M, Germano R, Mihova D, Macas J, et al. Low wnt/β-catenin signaling determines leaky vessels in the subfornical organ and affects water homeostasis in mice. elife. 2019;8: pubmed publisher
  26. Wang Y, Sabbagh M, Gu X, Rattner A, Williams J, Nathans J. Beta-catenin signaling regulates barrier-specific gene expression in circumventricular organ and ocular vasculatures. elife. 2019;8: pubmed publisher
  27. Yang Z, Huang C, Wu Y, Chen B, Zhang W, Zhang J. Autophagy Protects the Blood-Brain Barrier Through Regulating the Dynamic of Claudin-5 in Short-Term Starvation. Front Physiol. 2019;10:2 pubmed publisher
  28. Louveau A, Herz J, Alme M, Salvador A, Dong M, Viar K, et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci. 2018;21:1380-1391 pubmed publisher
  29. Wevers N, Kasi D, Gray T, Wilschut K, Smith B, van Vught R, et al. A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport. Fluids Barriers CNS. 2018;15:23 pubmed publisher
  30. Kim Y, Lee M, Gu H, Kim J, Jeong S, Yeo S, et al. HIF-1α activation in myeloid cells accelerates dextran sodium sulfate-induced colitis progression in mice. Dis Model Mech. 2018;11: pubmed publisher
  31. Rempe R, Hartz A, Soldner E, Sokola B, Alluri S, Abner E, et al. Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy. J Neurosci. 2018;38:4301-4315 pubmed publisher
  32. Kim J, Kim Y, Kim J, Park D, Bae H, Lee D, et al. YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. J Clin Invest. 2017;127:3441-3461 pubmed publisher
  33. Cho C, Smallwood P, Nathans J. Reck and Gpr124 Are Essential Receptor Cofactors for Wnt7a/Wnt7b-Specific Signaling in Mammalian CNS Angiogenesis and Blood-Brain Barrier Regulation. Neuron. 2017;95:1056-1073.e5 pubmed publisher
  34. Boussadia B, Lakhal L, Payrastre L, Ghosh C, Pascussi J, Gangarossa G, et al. Pregnane X Receptor Deletion Modifies Recognition Memory and Electroencephalographic Activity. Neuroscience. 2018;370:130-138 pubmed publisher
  35. Andreone B, Chow B, Tata A, Lacoste B, Ben Zvi A, Bullock K, et al. Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis. Neuron. 2017;94:581-594.e5 pubmed publisher
  36. Yanagida K, Liu C, Faraco G, Galvani S, Smith H, Burg N, et al. Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1. Proc Natl Acad Sci U S A. 2017;114:4531-4536 pubmed publisher
  37. Swanson P, Hart G, Russo M, Nayak D, Yazew T, Pena M, et al. CD8+ T Cells Induce Fatal Brainstem Pathology during Cerebral Malaria via Luminal Antigen-Specific Engagement of Brain Vasculature. PLoS Pathog. 2016;12:e1006022 pubmed publisher
  38. Bassett E, Tokarew N, Allemano E, Mazerolle C, Morin K, Mears A, et al. Norrin/Frizzled4 signalling in the preneoplastic niche blocks medulloblastoma initiation. elife. 2016;5: pubmed publisher
  39. Chehaibi K, le Maire L, Bradoni S, Escolà J, Blanco Vaca F, Slimane M. Effect of PPAR-β/δ agonist GW0742 treatment in the acute phase response and blood-brain barrier permeability following brain injury. Transl Res. 2017;182:27-48 pubmed publisher
  40. Gautam J, Zhang X, Yao Y. The role of pericytic laminin in blood brain barrier integrity maintenance. Sci Rep. 2016;6:36450 pubmed publisher
  41. Huang L, Cao W, Deng Y, Zhu G, Han Y, Zeng H. Hypertonic saline alleviates experimentally induced cerebral oedema through suppression of vascular endothelial growth factor and its receptor VEGFR2 expression in astrocytes. BMC Neurosci. 2016;17:64 pubmed
  42. Mendonça M, Soares E, de Jesus M, Ceragioli H, Batista Ã, Nyúl Tóth Ã, et al. PEGylation of Reduced Graphene Oxide Induces Toxicity in Cells of the Blood-Brain Barrier: An in Vitro and in Vivo Study. Mol Pharm. 2016;13:3913-3924 pubmed
  43. Gross S, Devraj K, Feng Y, Macas J, Liebner S, Wieland T. Nucleoside diphosphate kinase B regulates angiogenic responses in the endothelium via caveolae formation and c-Src-mediated caveolin-1 phosphorylation. J Cereb Blood Flow Metab. 2017;37:2471-2484 pubmed publisher
  44. Adam A, Lowery A, Martino N, Alsaffar H, Vincent P. Src Family Kinases Modulate the Loss of Endothelial Barrier Function in Response to TNF-α: Crosstalk with p38 Signaling. PLoS ONE. 2016;11:e0161975 pubmed publisher
  45. Ahn C, Shin D, Lee D, Kang S, Seok J, Kang H, et al. Expression of claudins, occludin, junction adhesion molecule A and zona occludens 1 in canine organs. Mol Med Rep. 2016;14:3697-703 pubmed publisher
  46. Yuan S, Pardue S, Shen X, Alexander J, Orr A, Kevil C. Hydrogen sulfide metabolism regulates endothelial solute barrier function. Redox Biol. 2016;9:157-166 pubmed publisher
  47. Jenny Zhou H, Qin L, Zhang H, Tang W, Ji W, He Y, et al. Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation. Nat Med. 2016;22:1033-1042 pubmed publisher
  48. Huang L, Stuart C, Takeda K, D Agnillo F, Golding B. Poly(I:C) Induces Human Lung Endothelial Barrier Dysfunction by Disrupting Tight Junction Expression of Claudin-5. PLoS ONE. 2016;11:e0160875 pubmed publisher
  49. Pang J, Wu Y, Peng J, Yang P, Kuai L, Qin X, et al. Potential implications of Apolipoprotein E in early brain injury after experimental subarachnoid hemorrhage: Involvement in the modulation of blood-brain barrier integrity. Oncotarget. 2016;7:56030-56044 pubmed publisher
  50. Zhang Z, Yan J, Shi H. Role of Hypoxia Inducible Factor 1 in Hyperglycemia-Exacerbated Blood-Brain Barrier Disruption in Ischemic Stroke. Neurobiol Dis. 2016;95:82-92 pubmed publisher
  51. Clark P, Al Ahmad A, Qian T, Zhang R, Wilson H, Weichert J, et al. Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood-Brain Barrier Model. Mol Pharm. 2016;13:3341-9 pubmed publisher
  52. Ge X, Huang S, Gao H, Han Z, Chen F, Zhang S, et al. miR-21-5p alleviates leakage of injured brain microvascular endothelial barrier in vitro through suppressing inflammation and apoptosis. Brain Res. 2016;1650:31-40 pubmed publisher
  53. Peckova K, Michal M, Hadravsky L, Suster S, Damjanov I, Miesbauerova M, et al. Littoral cell angioma of the spleen: a study of 25 cases with confirmation of frequent association with visceral malignancies. Histopathology. 2016;69:762-774 pubmed publisher
  54. Szalay G, Martinecz B, Lénárt N, Kornyei Z, Orsolits B, Judák L, et al. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat Commun. 2016;7:11499 pubmed publisher
  55. Liu W, Cai H, Lin M, Zhu L, Gao L, Zhong R, et al. MicroRNA-107 prevents amyloid-beta induced blood-brain barrier disruption and endothelial cell dysfunction by targeting Endophilin-1. Exp Cell Res. 2016;343:248-257 pubmed publisher
  56. Lee B, Kang H, Lee D, Ahn C, Jeung E. Claudin-1, -2, -4, and -5: comparison of expression levels and distribution in equine tissues. J Vet Sci. 2016;17:445-451 pubmed publisher
  57. Nishida Fukuda H, Araki R, Shudou M, Okazaki H, Tomono Y, Nakayama H, et al. Ectodomain Shedding of Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE-1) Is Induced by Vascular Endothelial Growth Factor A (VEGF-A). J Biol Chem. 2016;291:10490-500 pubmed publisher
  58. Gurnik S, Devraj K, Macas J, Yamaji M, Starke J, Scholz A, et al. Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling. Acta Neuropathol. 2016;131:753-73 pubmed publisher
  59. Sreekanthreddy P, Gromnicova R, Davies H, Phillips J, Romero I, Male D. A three-dimensional model of the human blood-brain barrier to analyse the transport of nanoparticles and astrocyte/endothelial interactions. F1000Res. 2015;4:1279 pubmed publisher
  60. Teng F, Zhu L, Su J, Zhang X, Li N, Nie Z, et al. Neuroprotective Effects of Poly(ADP-ribose)polymerase Inhibitor Olaparib in Transient Cerebral Ischemia. Neurochem Res. 2016;41:1516-26 pubmed publisher
  61. Schossleitner K, Rauscher S, Gröger M, Friedl H, Finsterwalder R, Habertheuer A, et al. Evidence That Cingulin Regulates Endothelial Barrier Function In Vitro and In Vivo. Arterioscler Thromb Vasc Biol. 2016;36:647-54 pubmed publisher
  62. Honig G, Mader S, Chen H, Porat A, Ochani M, Wang P, et al. Blood-Brain Barrier Deterioration and Hippocampal Gene Expression in Polymicrobial Sepsis: An Evaluation of Endothelial MyD88 and the Vagus Nerve. PLoS ONE. 2016;11:e0144215 pubmed publisher
  63. Lewandowski S, Nilsson I, Fredriksson L, Lönnerberg P, Muhl L, Zeitelhofer M, et al. Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration. Acta Neuropathol. 2016;131:453-64 pubmed publisher
  64. Zhou Y, Williams J, Smallwood P, Nathans J. Sox7, Sox17, and Sox18 Cooperatively Regulate Vascular Development in the Mouse Retina. PLoS ONE. 2015;10:e0143650 pubmed publisher
  65. Rodrigo Albors A, Tazaki A, Rost F, Nowoshilow S, Chara O, Tanaka E. Planar cell polarity-mediated induction of neural stem cell expansion during axolotl spinal cord regeneration. elife. 2015;4:e10230 pubmed publisher
  66. Stebbins M, Wilson H, Canfield S, Qian T, Palecek S, Shusta E. Differentiation and characterization of human pluripotent stem cell-derived brain microvascular endothelial cells. Methods. 2016;101:93-102 pubmed publisher
  67. Brkic M, Balusu S, Van Wonterghem E, Gorlé N, Benilova I, Kremer A, et al. Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases. J Neurosci. 2015;35:12766-78 pubmed publisher
  68. Zhao Y, Zhao L, Wang P, Miao Y, Liu Y, Wang Z, et al. Overexpression of miR-18a negatively regulates myocyte enhancer factor 2D to increase the permeability of the blood-tumor barrier via Krüppel-like factor 4-mediated downregulation of zonula occluden-1, claudin-5, and occludin. J Neurosci Res. 2015;93:1891-902 pubmed publisher
  69. Zehendner C, Sebastiani A, Hugonnet A, Bischoff F, Luhmann H, Thal S. Traumatic brain injury results in rapid pericyte loss followed by reactive pericytosis in the cerebral cortex. Sci Rep. 2015;5:13497 pubmed publisher
  70. Smith N, Hinley J, Varley C, Eardley I, Trejdosiewicz L, Southgate J. The human urothelial tight junction: claudin 3 and the ZO-1α+ switch. Bladder (San Franc). 2015;2:e9 pubmed
  71. Tan F, Fu W, Cheng N, Meng D, Gu Y. Ligustrazine reduces blood-brain barrier permeability in a rat model of focal cerebral ischemia and reperfusion. Exp Ther Med. 2015;9:1757-1762 pubmed
  72. Cai H, Xue Y, Wang P, Wang Z, Li Z, Hu Y, et al. The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144. Oncotarget. 2015;6:19759-79 pubmed
  73. Hyun Jo D, Lee R, Hyoung Kim J, Oh Jun H, Geol Lee T, Hun Kim J. Real-time estimation of paracellular permeability of cerebral endothelial cells by capacitance sensor array. Sci Rep. 2015;5:11014 pubmed publisher
  74. Louveau A, Smirnov I, Keyes T, Eccles J, Rouhani S, Peske J, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337-41 pubmed publisher
  75. Shah K, Boreddy P, Abbruscato T. Nicotine pre-exposure reduces stroke-induced glucose transporter-1 activity at the blood-brain barrier in mice. Fluids Barriers CNS. 2015;12:10 pubmed publisher
  76. Staat C, Coisne C, Dabrowski S, Stamatovic S, Andjelkovic A, Wolburg H, et al. Mode of action of claudin peptidomimetics in the transient opening of cellular tight junction barriers. Biomaterials. 2015;54:9-20 pubmed publisher
  77. Clark P, Kim R, Pober J, Kluger M. Tumor necrosis factor disrupts claudin-5 endothelial tight junction barriers in two distinct NF-κB-dependent phases. PLoS ONE. 2015;10:e0120075 pubmed publisher
  78. Sajja R, Green K, Cucullo L. Altered Nrf2 signaling mediates hypoglycemia-induced blood-brain barrier endothelial dysfunction in vitro. PLoS ONE. 2015;10:e0122358 pubmed publisher
  79. Muramatsu R, Kuroda M, Matoba K, Lin H, Takahashi C, Koyama Y, et al. Prostacyclin prevents pericyte loss and demyelination induced by lysophosphatidylcholine in the central nervous system. J Biol Chem. 2015;290:11515-25 pubmed publisher
  80. Ghersi Egea J, Babikian A, Blondel S, Strazielle N. Changes in the cerebrospinal fluid circulatory system of the developing rat: quantitative volumetric analysis and effect on blood-CSF permeability interpretation. Fluids Barriers CNS. 2015;12:8 pubmed publisher
  81. Meekins J, Eshar D, Rankin A, Henningson J. Clinical and histologic description of ocular anatomy in captive black-tailed prairie dogs (Cynomys ludovicianus). Vet Ophthalmol. 2016;19:110-6 pubmed publisher
  82. Boulay A, Mazeraud A, Cisternino S, Saubaméa B, Mailly P, Jourdren L, et al. Immune quiescence of the brain is set by astroglial connexin 43. J Neurosci. 2015;35:4427-39 pubmed publisher
  83. Sohet F, Lin C, Munji R, Lee S, Ruderisch N, Soung A, et al. LSR/angulin-1 is a tricellular tight junction protein involved in blood-brain barrier formation. J Cell Biol. 2015;208:703-11 pubmed publisher
  84. Licht T, Dor Wollman T, Ben Zvi A, Rothe G, Keshet E. Vessel maturation schedule determines vulnerability to neuronal injuries of prematurity. J Clin Invest. 2015;125:1319-28 pubmed publisher
  85. Nissi R, Talvensaari Mattila A, Kuvaja P, Pääkkö P, Soini Y, Santala M. Claudin-5 is associated with elevated TATI and CA125 levels in mucinous ovarian borderline tumors. Anticancer Res. 2015;35:973-6 pubmed
  86. Scotti L, Abramovich D, Pascuali N, Durand L, Irusta G, de Zúñiga I, et al. Inhibition of angiopoietin-1 (ANGPT1) affects vascular integrity in ovarian hyperstimulation syndrome (OHSS). Reprod Fertil Dev. 2016;28:690-9 pubmed publisher
  87. Cai H, Liu W, Xue Y, Shang X, Liu J, Li Z, et al. Roundabout 4 regulates blood-tumor barrier permeability through the modulation of ZO-1, Occludin, and Claudin-5 expression. J Neuropathol Exp Neurol. 2015;74:25-37 pubmed publisher
  88. Swager S, Delfín D, Rastogi N, Wang H, Canan B, Fedorov V, et al. Claudin-5 levels are reduced from multiple cell types in human failing hearts and are associated with mislocalization of ephrin-B1. Cardiovasc Pathol. 2015;24:160-167 pubmed publisher
  89. Rattner A, Wang Y, Zhou Y, Williams J, Nathans J. The role of the hypoxia response in shaping retinal vascular development in the absence of Norrin/Frizzled4 signaling. Invest Ophthalmol Vis Sci. 2014;55:8614-25 pubmed publisher
  90. Braniste V, Al Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014;6:263ra158 pubmed publisher
  91. Johnson H, Willenbring R, Jin F, Manhart W, Lafrance S, Pirko I, et al. Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption. PLoS ONE. 2014;9:e111401 pubmed publisher
  92. Casselbrant A, Elias E, Fändriks L, Wallenius V. Expression of tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2015;11:45-53 pubmed publisher
  93. Albert Weissenberger C, Mencl S, Schuhmann M, Salur I, Göb E, Langhauser F, et al. C1-Inhibitor protects from focal brain trauma in a cortical cryolesion mice model by reducing thrombo-inflammation. Front Cell Neurosci. 2014;8:269 pubmed publisher
  94. Scotti L, Abramovich D, Pascuali N, Irusta G, Meresman G, Tesone M, et al. Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome. J Steroid Biochem Mol Biol. 2014;144 Pt B:392-401 pubmed publisher
  95. Zhou Y, Wang Y, TISCHFIELD M, Williams J, Smallwood P, Rattner A, et al. Canonical WNT signaling components in vascular development and barrier formation. J Clin Invest. 2014;124:3825-46 pubmed publisher
  96. Virman J, Soini Y, Kujala P, Luukkaala T, Salminen T, Sunela K, et al. Claudins as prognostic factors for renal cell cancer. Anticancer Res. 2014;34:4181-7 pubmed
  97. Yang N, Liu Y, Pan C, Sun K, Wei X, Mao X, et al. Pretreatment with andrographolide pills(®) attenuates lipopolysaccharide-induced pulmonary microcirculatory disturbance and acute lung injury in rats. Microcirculation. 2014;21:703-16 pubmed publisher
  98. Takeshita Y, Obermeier B, Cotleur A, Sano Y, Kanda T, Ransohoff R. An in vitro blood-brain barrier model combining shear stress and endothelial cell/astrocyte co-culture. J Neurosci Methods. 2014;232:165-72 pubmed publisher
  99. Ben Zvi A, Lacoste B, Kur E, Andreone B, Mayshar Y, Yan H, et al. Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature. 2014;509:507-11 pubmed publisher
  100. Sajja R, Prasad S, Cucullo L. Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line. Fluids Barriers CNS. 2014;11:8 pubmed publisher
  101. Zehendner C, White R, Hedrich J, Luhmann H. A neurovascular blood-brain barrier in vitro model. Methods Mol Biol. 2014;1135:403-13 pubmed publisher
  102. Zehendner C, Librizzi L, Hedrich J, Bauer N, Angamo E, de Curtis M, et al. Moderate hypoxia followed by reoxygenation results in blood-brain barrier breakdown via oxidative stress-dependent tight-junction protein disruption. PLoS ONE. 2013;8:e82823 pubmed publisher
  103. Zehendner C, Wedler H, Luhmann H. A novel in vitro model to study pericytes in the neurovascular unit of the developing cortex. PLoS ONE. 2013;8:e81637 pubmed publisher
  104. Hawkins K, Demars K, Singh J, Yang C, Cho H, Frankowski J, et al. Neurovascular protection by post-ischemic intravenous injections of the lipoxin A4 receptor agonist, BML-111, in a rat model of ischemic stroke. J Neurochem. 2014;129:130-42 pubmed publisher
  105. Watson P, Paterson J, Thom G, Ginman U, Lundquist S, Webster C. Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier. BMC Neurosci. 2013;14:59 pubmed publisher
  106. Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature. 2013;498:492-6 pubmed publisher
  107. Szczepkowska A, Lagaraine C, Robert V, Dufourny L, Thiery J, Skipor J. Effect of a two-week treatment with a low dose of 2,2'4,4',5,5'-hexachlorobiphenyl (PCB153) on tight junction protein expression in ovine choroid plexus during long and short photoperiods. Neurotoxicol Teratol. 2013;37:63-7 pubmed publisher
  108. Nordfors K, Haapasalo J, Sallinen P, Haapasalo H, Soini Y. Expression of claudins relates to tumour aggressivity, location and recurrence in ependymomas. Histol Histopathol. 2013;28:1137-46 pubmed publisher
  109. Strazielle N, Ghersi Egea J. Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules. Mol Pharm. 2013;10:1473-91 pubmed publisher
  110. Lappi Blanco E, Lehtonen S, Sormunen R, Merikallio H, Soini Y, Kaarteenaho R. Divergence of tight and adherens junction factors in alveolar epithelium in pulmonary fibrosis. Hum Pathol. 2013;44:895-907 pubmed publisher
  111. Wang Y, Rattner A, Zhou Y, Williams J, Smallwood P, Nathans J. Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity. Cell. 2012;151:1332-44 pubmed publisher
  112. Krouwer V, Hekking L, Langelaar Makkinje M, Regan Klapisz E, Post J. Endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability. Vasc Cell. 2012;4:12 pubmed publisher
  113. Kratzer I, Vasiljevic A, Rey C, Fevre Montange M, Saunders N, Strazielle N, et al. Complexity and developmental changes in the expression pattern of claudins at the blood-CSF barrier. Histochem Cell Biol. 2012;138:861-79 pubmed publisher
  114. Northrop N, Yamamoto B. Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier. J Neuroimmune Pharmacol. 2012;7:951-68 pubmed publisher
  115. Johnson H, Chen Y, Jin F, Hanson L, Gamez J, Pirko I, et al. CD8 T cell-initiated blood-brain barrier disruption is independent of neutrophil support. J Immunol. 2012;189:1937-45 pubmed publisher
  116. Raposo C, Odorissi P, Oliveira A, Aoyama H, Ferreira C, Verinaud L, et al. Effect of Phoneutria nigriventer venom on the expression of junctional protein and P-gp efflux pump function in the blood-brain barrier. Neurochem Res. 2012;37:1967-81 pubmed publisher
  117. Delfin D, Xu Y, Schill K, Mays T, Canan B, Zang K, et al. Sustaining cardiac claudin-5 levels prevents functional hallmarks of cardiomyopathy in a muscular dystrophy mouse model. Mol Ther. 2012;20:1378-83 pubmed publisher
  118. Géraud C, Evdokimov K, Straub B, Peitsch W, Demory A, Dörflinger Y, et al. Unique cell type-specific junctional complexes in vascular endothelium of human and rat liver sinusoids. PLoS ONE. 2012;7:e34206 pubmed publisher
  119. Ghule V, Gray C, Galimberti A, Anumba D. Prostaglandin-induced cervical remodelling in humans in the first trimester is associated with increased expression of specific tight junction, but not gap junction proteins. J Transl Med. 2012;10:40 pubmed publisher
  120. Riski M, Santala M, Soini Y, Talvensaari Mattila A. Claudins 1, 3M, 3S, 4, 5 and 7 in vulvar neoplasms compared with vulvar squamous cell carcinoma. Tumour Biol. 2012;33:537-42 pubmed publisher
  121. Lecuyer H, Nassif X, Coureuil M. Two strikingly different signaling pathways are induced by meningococcal type IV pili on endothelial and epithelial cells. Infect Immun. 2012;80:175-86 pubmed publisher
  122. Pfeiffer F, Schäfer J, Lyck R, Makrides V, Brunner S, Schaeren Wiemers N, et al. Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis. Acta Neuropathol. 2011;122:601-14 pubmed publisher
  123. Miettinen M, Sarlomo Rikala M, Wang Z. Claudin-5 as an immunohistochemical marker for angiosarcoma and hemangioendotheliomas. Am J Surg Pathol. 2011;35:1848-56 pubmed publisher
  124. Mandel I, Paperna T, Glass Marmor L, Volkowich A, Badarny S, Schwartz I, et al. Tight junction proteins expression and modulation in immune cells and multiple sclerosis. J Cell Mol Med. 2012;16:765-75 pubmed publisher
  125. Lagaraine C, Skipor J, Szczepkowska A, Dufourny L, Thiery J. Tight junction proteins vary in the choroid plexus of ewes according to photoperiod. Brain Res. 2011;1393:44-51 pubmed publisher
  126. Zehendner C, Librizzi L, de Curtis M, Kuhlmann C, Luhmann H. Caspase-3 contributes to ZO-1 and Cl-5 tight-junction disruption in rapid anoxic neurovascular unit damage. PLoS ONE. 2011;6:e16760 pubmed publisher
  127. Butt O, Buehler P, D Agnillo F. Blood-brain barrier disruption and oxidative stress in guinea pig after systemic exposure to modified cell-free hemoglobin. Am J Pathol. 2011;178:1316-28 pubmed publisher
  128. Koda R, Zhao L, Yaoita E, Yoshida Y, Tsukita S, Tamura A, et al. Novel expression of claudin-5 in glomerular podocytes. Cell Tissue Res. 2011;343:637-48 pubmed publisher
  129. Manias J, Kapadia A, Nag S. Detection of multiple proteins in intracerebral vessels by confocal microscopy. Methods Mol Biol. 2011;686:177-92 pubmed publisher
  130. Su S, Maxwell S, Bayless K. Annexin 2 regulates endothelial morphogenesis by controlling AKT activation and junctional integrity. J Biol Chem. 2010;285:40624-34 pubmed publisher
  131. Powner M, Gillies M, Tretiach M, Scott A, Guymer R, Hageman G, et al. Perifoveal müller cell depletion in a case of macular telangiectasia type 2. Ophthalmology. 2010;117:2407-16 pubmed publisher
  132. Turunen M, Talvensaari Mattila A, Soini Y, Santala M. Claudin-5 overexpression correlates with aggressive behavior in serous ovarian adenocarcinoma. Anticancer Res. 2009;29:5185-9 pubmed
  133. Shen W, Li S, Chung S, Gillies M. Retinal vascular changes after glial disruption in rats. J Neurosci Res. 2010;88:1485-99 pubmed publisher
  134. Bauer A, Bürgers H, Rabie T, Marti H. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab. 2010;30:837-48 pubmed publisher
  135. HERRERA J, Haywood Watson R, Grill R. Acute and chronic deficits in the urinary bladder after spinal contusion injury in the adult rat. J Neurotrauma. 2010;27:423-31 pubmed publisher
  136. Sadowska G, Malaeb S, Stonestreet B. Maternal glucocorticoid exposure alters tight junction protein expression in the brain of fetal sheep. Am J Physiol Heart Circ Physiol. 2010;298:H179-88 pubmed publisher
  137. Yemisci M, Gursoy Ozdemir Y, Vural A, Can A, Topalkara K, Dalkara T. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med. 2009;15:1031-7 pubmed publisher
  138. Regan Klapisz E, Krouwer V, Langelaar Makkinje M, Nallan L, Gelb M, Gerritsen H, et al. Golgi-associated cPLA2alpha regulates endothelial cell-cell junction integrity by controlling the trafficking of transmembrane junction proteins. Mol Biol Cell. 2009;20:4225-34 pubmed publisher
  139. Waldow T, Witt W, Janke A, Ulmer A, Buzin A, Matschke K. Cell-cell junctions and vascular endothelial growth factor in rat lung as affected by ischemia/reperfusion and preconditioning with inhaled nitric oxide. J Surg Res. 2009;157:30-42 pubmed publisher
  140. Alanne M, Pummi K, Heape A, Grenman R, Peltonen J, Peltonen S. Tight junction proteins in human Schwann cell autotypic junctions. J Histochem Cytochem. 2009;57:523-9 pubmed publisher
  141. Kaarteenaho Wiik R, Soini Y. Claudin-1, -2, -3, -4, -5, and -7 in usual interstitial pneumonia and sarcoidosis. J Histochem Cytochem. 2009;57:187-95 pubmed publisher
  142. Neuhaus W, Wirth M, Plattner V, Germann B, Gabor F, Noe C. Expression of Claudin-1, Claudin-3 and Claudin-5 in human blood-brain barrier mimicking cell line ECV304 is inducible by glioma-conditioned media. Neurosci Lett. 2008;446:59-64 pubmed publisher
  143. Su S, Mendoza E, Kwak H, Bayless K. Molecular profile of endothelial invasion of three-dimensional collagen matrices: insights into angiogenic sprout induction in wound healing. Am J Physiol Cell Physiol. 2008;295:C1215-29 pubmed publisher
  144. Norsted E, Gömüç B, Meister B. Protein components of the blood-brain barrier (BBB) in the mediobasal hypothalamus. J Chem Neuroanat. 2008;36:107-21 pubmed publisher
  145. Reynolds G, Harris H, Jennings A, Hu K, Grove J, Lalor P, et al. Hepatitis C virus receptor expression in normal and diseased liver tissue. Hepatology. 2008;47:418-27 pubmed
  146. Akat K, Bleck C, Lee Y, Haselmann Weiss U, Kartenbeck J. Characterization of a novel type of adherens junction in meningiomas and the derived cell line HBL-52. Cell Tissue Res. 2008;331:401-12 pubmed
  147. McCaffrey G, Staatz W, Quigley C, Nametz N, Seelbach M, Campos C, et al. Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo. J Neurochem. 2007;103:2540-55 pubmed publisher
  148. Uehara K, Uehara A. Localization of claudin-5 and ZO-1 in rat spleen sinus endothelial cells. Histochem Cell Biol. 2008;129:95-103 pubmed
  149. Takala H, Saarnio J, Wiik H, Soini Y. Claudins 1, 3, 4, 5 and 7 in esophageal cancer: loss of claudin 3 and 4 expression is associated with metastatic behavior. APMIS. 2007;115:838-47 pubmed
  150. Paschoud S, Bongiovanni M, Pache J, Citi S. Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas. Mod Pathol. 2007;20:947-54 pubmed
  151. Morgan L, Shah B, Rivers L, Barden L, Groom A, Chung R, et al. Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis. Neuroscience. 2007;147:664-73 pubmed
  152. Peltonen S, Riehokainen J, Pummi K, Peltonen J. Tight junction components occludin, ZO-1, and claudin-1, -4 and -5 in active and healing psoriasis. Br J Dermatol. 2007;156:466-72 pubmed
  153. Bello I, Soini Y, Slootweg P, Salo T. Claudins 1, 4, 5, 7 and occludin in ameloblastomas and developing human teeth. J Oral Pathol Med. 2007;36:48-54 pubmed
  154. Soini Y, Kinnula V, Kahlos K, Paakko P. Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura. J Clin Pathol. 2006;59:250-4 pubmed
  155. Pummi K, Aho H, Laato M, Peltonen J, Peltonen S. Tight junction proteins and perineurial cells in neurofibromas. J Histochem Cytochem. 2006;54:53-61 pubmed
  156. Brandner J, McIntyre M, Kief S, Wladykowski E, Moll I. Expression and localization of tight junction-associated proteins in human hair follicles. Arch Dermatol Res. 2003;295:211-21 pubmed
  157. Wang F, Daugherty B, Keise L, Wei Z, Foley J, Savani R, et al. Heterogeneity of claudin expression by alveolar epithelial cells. Am J Respir Cell Mol Biol. 2003;29:62-70 pubmed